Severe asthma patients had higher inhaled corticosteroid doses and rates of concomitant controller use and lower total IgE levels and lower pulmonary function, except for forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC), than those without severe asthma (Table I). This evidence concerns the gene IGHE and asthma.